在 κ-阿片类受体中的连接体和G蛋白选择性
Jianming Han1,2, Jingying Zhang3,4,5,6, Antonina L Nazarova7,8,9
1Department of Anesthesiology, Washington University in St Louis, St Louis, MO, USA.
Nature
|May 3, 2023
概括
κ-阿片类受体 (KOR) 是疼痛和上的目标, 但副作用是一个问题. 新结构揭示了KOR与不同G蛋白的相互作用,指导开发更安全的KOR向药物.
科学领域:
- 神经科学
- 分子生物学
- 药理学
背景情况:
- κ-阿片类受体 (KOR) 是治疗疼痛,成和情感障碍的关键点.
- 针对KOR的治疗方法的开发受到幻觉性副作用的限制.
- KOR信号涉及Gi/o家族蛋白质 (Gi1,Gi2,Gi3,GoA,GoB,Gz,Gg),但它们的特定作用和亚型选择性尚不清楚.
研究的目的:
- 阐明KOR与各种Gi/o家族亚型相互作用的结构基础.
- 了解KOR连体选择性和G蛋白亚型选择性的分子机制.
- 为设计具有改善治疗特征的选择性KOR激动剂提供基础.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定KOR的活性状态结构.
- 用Gi1,GoA,Gz和Gg异构体进行了复杂的解析.
- 复合物与幻觉性萨尔维诺林或选择性KOR激动剂结合.
主要成果:
- 获得了KOR与四种不同的G蛋白亚型 (Gi1,GoA,Gz,Gg) 结合的详细结构.
- 确定了控制KOR- G蛋白相互作用和G蛋白亚型选择性的分子决定因素.
- 在四种G蛋白亚型中观察到结合亲和力和性活性的差异.
结论:
- 这项研究揭示了对KOR-G蛋白合特异性和连接体选择性的关键见解.
- 结构数据为了解KOR的幻觉作用提供了基础.
- 这些发现为开发选择性KOR激动剂铺平了道路,以减轻副作用并增强治疗潜力.
相关概念视频
Opioid Receptors: Overview
1.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K
GPCR Desensitization
6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K
G Protein-coupled Receptors
12.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.4K
Analgesia and Pain Management
686
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
686


